Summary Etoposide (VP-16) is an anti-cancer drug commonly used against several types of tumours and leukaemia, either alone or in combination chemotherapy. Photodynamic therapy (PDT) is another, relatively new modality for treatment of various malignancies. The interactions between VP-16 and PDT, using aluminium tetrasulphophthalocyanine as photosensitiser, in K562 human leukaemic cells were investigated. Cell responses to individual and combined drug treatment under different experimental conditions revealed synergistic drug toxicity. The latter was evident from various events of cell response, including supra-additive accumulation of cells in G2/M cell cycle phase and endonucleolytic DNA fragmentation (apoptosis). The involvement of the cellular antioxidant system in the synergistic interactions of photosensitisation and VP-16 is proposed.
agent used against several tumour types, either alone (Issel et al., 1984) , or in combination therapy (Aisner and Lee, 1991) . Etoposide is also commonly used for the treatment of acute myelogenous leukaemia (Champlin and Gale, 1987) . The cytotoxicity of VP-1 6 is generally believed to be based on introduction of DNA damage by drug interference with breakage -reunion reaction of DNA -topoisomerase II (formation of DNA -protein cross-links) (Glisson and Ross, 1987; Liu, 1989) and/or induction of direct DNA strand breaks and adducts (van Maanen et al., 1988a, b; Mans et al., 1991) . In contrast to the topoisomerase II (topo II) poisoning by VP-16 itself, the direct inactivation of DNA was suggested to be conjugated with oxidation-reduction activation of in the cellular environment (Mans et al., 1990 (Mans et al., , 1992 . In particular, cytochrome P450-dependent mono-oxygenases, peroxidases, prostaglandin synthetase, tyrosinase, etc. may be involved in metabolic transformation (van Maanen et al., 1987; Haim et al., 1991; Gantchev et al., 1994a) . Evidence has been found that peroxidative metabolic products of e .g. the ortho-quinone derivative of etoposide, as well as the short-lived intermediates (phenoxyl and semi-quinone free radicals) are involved in various oxidative reactions and DNA damage (Mans et al., 1990 (Mans et al., , 1991 Sinha et al., 1990) . Recent studies suggest that the interactions of VP-16 free radicals with intracellular reductants (thiols, ascorbic acid, etc.) might play an essential role in the cytotoxic activity of the drug as well (Mans et al., 1992; Kagan et al., 1994; Yokomizo et al., 1995) .
Light activation of photosensitisers that have been accumulated in tumours is the basis of the photodynamic therapy (PDT) of cancer. Cytotoxic action of photosensitisers may involve oxidative damage to different cell constituents, including depletion of the pool of cell antioxidants (free and protein-bound thiols, ascorbic acid, a-tocopherol, etc.) (Buettner, 1984, Shopova and Gantchev, 1990, Gantchev and Lier, 1995) . Metallo-phthalocyanines (MePc) constitute a class of dyes proposed as second-generation photodynamic agents to supplant Photofrin, a mixture of porphyrin derivatives, currently used in the clinical treatment of various malignancies. Highly water-soluble phthalocyaCorrespondence: TG Gantchev Received 28 March 1996; revised 4 June 1996; accepted 12 June 1996 nines, such as di-through tetrasulphonated derivatives (MePcS2 4) partially localise in cytoplasm and photosensitise intracellular generation of hydroxyl and organic free radicals (Gantchev et al., 1994b) . Among different effects of photosensitised cell damage, tetrasulphonated Al-and ZnPcS4 have been shown to weaken cell viability by inactivation of catalase (Gantchev and van Lier, 1995) and inflicting damage to DNA (Hunting et al., 1987; Gantchev et al., 1994c) . We have also shown that these phthalocyanines can initiate oxidative transformations of in solution via photosensitised generation of VP-16 phenoxyl radical (Gantchev et al., 1994a) .
In view of the above properties of phthalocyanines and the interrelation between the rate of VP-16 oxidative transformation, its cytotoxicity, and the activity of intracellular antioxidant systems, we hypothesised that PDT, in conjunction with etoposide, could result in enhanced cytotoxicity. Analysis of different effects of combination therapy with To analyse the dose -effect relationships in combination treatment of cells with VP-16 and AlPcS4 photosensitisation, two algorithms were used. A simple estimate was performed using the fractional product method (Veleriote and Liu, 1975) . This 'multiplicative' model predicts additivity, antagonism and/or synergism of two drugs based on the comparison between the individual drug effect on cell survival, fu (expected) = (fu)I x (fu)2 and the experimentally obtained value of cell survival after combination treatment, (f),2. The symbol (f0),2 stands for 'fraction unaffected' and is equal to 1-(f)L,2, where fa ('fraction affected') refers to the fraction of cells responding to various concentrations of the two drugs in combination. By definition, (u)1,2 lower, equal to or larger than fu (expected) determines the border lines of synergistic (supra-additive), additive and antagonistic drug interactions respectively. In a specially designed set of experiments, we also performed a detailed analysis of drug interactions using the median effect principle. Unlike other methods often used to predict drug interactions in biological systems (usually applicable only to mutually exclusive interactions), the median effect principle may be used to analyse both mutually exclusive and mutually non-exclusive interactions (Chou and Talalay, 1983) . We used the linearised median effect equation in the form of log [(fu) -'-1] = m log (D) -m log (Din), where 'm' is the Hill-type coefficient determining the sigmoidality of the dose -effect curve; 'D' is drug(s) dose; and Dm = IC50 is the dose required to produce the median effect. The combination index (CI) was calculated at fa levels of 0.1 intervals, as described by Chou and Talalay (1983 Resuspended in 20 pl TE buffer, pellets were incubated with 0.8 mg ml-' RNAase A at 37°C for 3 h. After mixing with 4 p1 of 6 x loading buffer (TE/ bromophenol/glycerol), samples were transferred onto 1.2% agarose gel and electrophoresed at 40 V for 4 h. Gels were stained for 40 min with 10 ng ml-' ethidium bromide, destained for 30-60 min in distilled water and photographed under UV light. Series of experiments were performed to selected post-treatment time periods and number of cells required to give early and easily detectable DNA fragmentation in combination with selected multiple drug dose equivalents to reveal drug interaction.
Results
Cell growth and loss of clonogenicity To determine the toxicity range of individual drugs and their combination effects, several parameters were examined: incubation times of cells with drugs, drug concentrations and the applied light dose for AlPcS4 activation. The cellular response to drug treatment was followed by monitoring the growth rate and cell clonogenic activity. Growth curves shown in Figure 1 exemplify the evolution of immediate drug toxicity with respect to drug incubation time, concentrations and light dose. For individual drugs and their combinations, growth curves show a proliferation lag period, followed either by predominant cell regrowth or cell death. At low levels of drug treatment (Figure la and b) , and during the initial proliferation lag-times (e.g. at post-treatment times shorter than 24 h), the number of dead cells did not exceed 5-8% of the total, but cell cycle progression was largely inhibited (see below). Figure 2 demonstrates (Krishan et al., 1975) . In the present study, the cells were incubated with VP-16 for given time periods, and, thereafter, the drug was removed. Under (Figure 4a ). The cell accumulation in G2/M was accompanied by a depletion, mainly of S-phase population, with very little variation in the GI-phase content. During combined treatment, the cells were also arrested in G2/M (Figure 3) . The extent of cell response after combined treatment varied and depended on the individual drug effect. Thus, in conditions when individual drugs were relatively more toxic (e.g. at doses approximately equal to the IC50, see also Figure lb ) and the maximum fraction of cells arrested by individual drug treatment was close to 60%, there was no significant increase in the G2/M population after combined treatment. However, under these conditions, the maximum number of G2/M-arrested cells after combined treatment was reached at later times and the total proliferation block lasted longer (Figure 4a ). It is noteworthy that in these conditions, during the growth lag period and after that, the number of dead cells remained relatively high, as also seen in DNA chromatograms exhibiting a higher percentage of cells with abnormal DNA content (debris and, perhaps, apoptotic cells). In contrast, when the toxic effects of individual drugs were low (growth curve shown in Figure  la) , combined treatment induced a supra-additive (synergistic) accumulation of cells in G2/M-phase, as also proved by the 'multiplicative' model (Figure 4b Figure 5 , however, it is evident that simultaneous employment of VP-16 with photodynamic treatment induces supra-additive increase of DNA fragmentation.
Median effect -combination index analysis
The results shown in previous sections indicate that drug combination treatment in most experimental conditions is supra-additive (synergistic). To evaluate modes of drug interactions, we designed experiments suitable for application of combination index analysis. This analysis is based on the median effect principle and is a statistical technique that allows formal evaluation of the nature of interaction between two cytotoxic agents. Cells were incubated with different concentrations of drugs, but at constant molar ratio (VP-16/ AlPcS4 = 1/2). Before irradiation, the cells were exposed to AlPcS4 for 1.5 h, followed by co-incubation with VP-16 for 0.5 h. Thereafter, the cells were washed and irradiated (D = 7.2 J cm-2). Drug toxicity was assessed by their effect on growth rate and clonogenicity. Figure 6 demonstrates that, under these conditions, the AlPcS4 phototoxicity was low, as estimated by both growth rate inhibition and loss of clonogenicity. However, growth rate assessment of toxicity underestimates the reproductive toxicity of the drug ( Figure 6 ). The median effect plots derived from cloning experiments and linear regression data fit are shown in Figure  7 . The dose-effect relationships of the individual drugs are strictly linear (r > 0.999, lines 1 and 2), while the plot obtained for the mixture of the two drugs tends to concave upward (r = 0.99) and intersects the plot of the more active drug (Figure 7 , line 3). It is, therefore, apparent that the combined drug action is synergistic. This was further confirmed by calculating the combination index values (CI) for a wide range offa ('fraction affected', Figure 8 ). Since the plots for the individual drugs are almost parallel (lines 1 and 2 in Figure 7) , and the plot for the combined treatment (line 3) intersects the plot of the more active drug, it is likely that the two drugs interact as mutually non-exclusive. The combination index was calculated assuming both possibilities, mutually exclusive and non-exclusive interactions. The plots shown in Figure 8 indicate that these two models predict synergistic toxicity (CI < 1) under conditions in which combined treatment results in fa >0.10 or fa >0. 15 respectively. For a comparison, CI values obtained from growth inhibition data were also calculated and included in Figure 8 . It can be seen that synergism in the latter case is somewhat overestimated, probably due to the underestimation of VP-16 toxicity by this criterion.
Discussion
We have investigated the effects of individual toxicity of etoposide (VP-16) and photodynamic treatment with AlPcS4, as well as the efficacy of drug combination against K562 human leukaemic cells. Similarly, in our previous studies with Namalva Burkitt's lymphoma cells (Gantchev et al., 1994b , photosensitisation of K562 cells results in division block and, depending on the extent of the treatment, is followed either by cell regrowth or by predominant cell death. Unlike photosensitisation with Photofrin, which induces S-phase cell cycle arrest (Gantchev et al., 1994d) (Mans et al., 1991 (Mans et al., , 1992 Ritov et al., 1995) . It is, however, kic toxicity of the noteworthy that the intracellular accumulation of these as calculated for products depends strongly on the presence of cellular Kclusive drugs (Fi, antioxidants (e.g. reduced ascorbate and thiols) (Gantchev et al., 1994a; Kagan et al., 1995) . The combination index analysis of AlPcS4 photosensitisation and VP-16 treatment as performed in the present work largely predicts synergistic toxicity of the two drugs. The of AlPcS4-PDT, experiments throughout this study were performed so that P-16. In particueffects, such as cell synchronisation, were avoided and cannot inhibition develaccount for the observed synergy. Moreover, the median J a lower level of effect plot of combined toxicity (Figure 7) Maanen et al., 1988b; Mans et al., 1990 Mans et al., , 1991 Sinha et ty (Figure 2 ) and al., 1990) can instantly induce damage to DNA. Therefore, se (Figure 3b and based on the assumption that metabolic oxidoreductive ity) in cell cycle transformations of VP-16 are important for its cytotoxic I cells arrested by action, we suggest that photosensitisation-induced depletion ralue of approxiof intracellular reductants facilitates VP-16 metabolism, trresponds to the probably on the level of VP-16 phenoxyl free radical -owing K562 cells transformations. Generation of the VP-16 phenoxyl radical vely affects cells is the primary step in the enzymatic metabolism of the drug r combined drug and the interactions of the phenoxyl radical with cell tf cells in G2/Mantioxidants prevents etoposide from further transformainternucleosomal tions and results in recovery of its original form. Also, the fore, likely that VP-16 phenoxyl radical may itself initiate oxidative cell ty combined drug damage (Ritov et al., 1995) . A parallel drug interaction out from the cell mechanism may involve direct AlPcS4-mediated photoThe molecular oxidation of VP-16 to yield the phenoxyl radical (Gantchev cS4-PDT-induced et al., 1994a) . Complete elucidation of the role of these ly. However, we different pathways and the involvement of additional pholipases C and processes that may explain the observed synergistic drug ;e during phototoxicity will require further experimental work. It is relevant ocalising (unsub- to note that a recent study showed synergism in cells e latter case, the subjected to gamma radiation and etoposide treatment , and it has been (Haddock et al., 1995) . Since the oxidative processes induced by PDT and radiotherapy are similar, it is possible that the synergistic interactions with etoposide are based on the same mechanisms. Although the presented results only involve in vitro synergy between photodynamic treatment and etoposide toxicity, our findings may provide alternative perspectives for clinical PDT and etoposide applications.
